Open Access Cell Biology
at Taylor & Francis
Taylor & Francis has a wide range of fully Open Access cell biology journals. Each journal has a rigorous peer review process that will validate your research, providing constructive feedback to publish the best version of your manuscript. Browse the collection below to learn more about each journal and find the perfect home for your research.
Cell Adhesion & Migration
Cell Adhesion & Migration is a multi-disciplinary, peer reviewed open access journal that focuses on the biological or pathological implications of cell-cell and cell-microenvironment interactions.
Cell Adhesion & Migration also publishes articles related to cell biomechanics, biomaterial, and development of related imaging technologies. Relevant topics include (but are not be limited to):
• Assembly of cell adhesion complexes
• Biological functions and molecular interactions of ECM molecules
• Cytoskeleton plasticity and related signalling cascades
• Cell fusion and cell intercalation
• Immune synapse formation
• Axon growth and guidance
• Cell biomechanics
• Development of imaging technologies
Channels is an open access journal for all aspects of ion channel research. The journal publishes high quality papers that shed new light on ion channel and ion transporter/exchanger function, structure, biophysics, pharmacology, and regulation in health and disease.
Channels welcomes interdisciplinary approaches that address ion channel physiology in areas such as neuroscience, cardiovascular sciences, cancer research, endocrinology, and gastroenterology.
Nucleus is a fully open access peer-reviewed journal, providing a platform to disseminate cutting-edge research on all aspects of biology of the cell nucleus.
Bringing together a multidisciplinary community of scientists, topics of interest include:
• Nuclear structure and dynamics
• Subnuclear organelles
• Chromatin organization
• Nuclear transport
• DNA replication and DNA damage repair
• Gene expression and RNA processing
• Nucleus in signaling and development
Adipocyte recognizes that the adipose tissue is the largest endocrine organ in the body, and explores the link between dysfunctional adipose tissue and the growing number of chronic diseases including diabetes, hypertension, cardiovascular disease and cancer.
The field of Adipose Tissue research has grown tremendously, and Adipocyte is the first international peer-reviewed journal of its kind providing a multi-disciplinary forum for research focusing exclusively on all aspects of adipose tissue physiology and pathophysiology. Adipocyte accepts high-profile submissions in basic, translational and clinical research.
Redox Report is a multidisciplinary, peer-reviewed open access journal publishing communications in free radical research.
Redox Report focuses on the role of free radicals, oxidative stress, activated oxygen, perioxidative and redox processes, primarily in the human environment and human pathology. Relevant papers on the animal and plant environment, biology and pathology will also be included.
- Emphasis is placed upon methodological and intellectual advances underpinned by new data.
- The journal offers scope for review, hypotheses, critiques and other forms of discussion.
- The journal accepts rapid publication of review articles in developing areas of research, as well as articles highlighting 'classic' papers in free radical research.
- The journal is essential for Biochemists, Cell biologists, Chemists, Clinicians, Pathophysiologists and all those concerned with free radicals.
2018 Impact Factor 4.405
mAbs is a multi-disciplinary journal dedicated to the art and science of antibody research and development.
Original research papers may cover all topics important in the antibody field, including studies of targeted proteins that are not antibody-based. Reviews, commentaries and perspectives on any aspect of antibody R&D are welcome. Relevant topics include (but are not be limited to):
• Antibody engineering and selection
• Targets relevant to cancer, immune-mediated disorders, and other diseases
• Non-clinical studies of antibodies, e.g., mechanism of action studies, safety and efficacy studies in animals
• Clinical studies
• Regulatory review of antibody therapeutics
• Post-approval topics, e.g., pricing, reimbursement and markets
• Emerging markets for antibody therapeutics, including China and India
Journal of Enzyme Inhibition and Medicinal Chemistry
2018 Impact Factor 4.027
An international and interdisciplinary open access journal, publishing new knowledge and findings on enzyme inhibitors and inhibitory processes, and agonist/antagonist receptor interactions in the development of medicinal and anti-cancer agents.
The Journal publishes research papers, short communications and reviews on current developments in enzymology, cell biology, chemical biology, microbiology, physiology, pharmacology leading to drug design, molecular recognition processes and distribution and metabolism of biologically active compounds. Among the various fields of study, special attention is given to structure and molecular aspects, enzyme kinetics and inactivation mechanisms, structure-activity relationships (QSAR, graphic techniques), drug development studies, drug release and control mechanisms in metabolic processes.
Mitochondrial DNA Part B
This open access journal publishes high-quality and concise research articles reporting the sequence of full mitochondrial genomes, and rapid communications focusing on the physical, chemical, and biochemical aspects of mtDNA and proteins involved in mtDNA metabolism and interactions.
Mitochondrial DNA Part B: Resources publishes high quality mitochondrial DNA announcement papers (short reports on whole mitochondrial DNA genomes) and rapid communications. It is the open access sister journal to Mitochondrial DNA Part A. The journal considers high-quality rapid communications on the following topics:
• Physical, chemical, and biochemical aspects of mtDNA and proteins involved in mtDNA metabolism, and/or interactions
• Population genetics, phylogenetics and human evolution that use mitochondrial DNA as a source of evidence for studies
• Human mitochondrial disorders and the utility of mitochondrial DNA information in medical studies
• Unique methodological or algorithmic approaches to the analysis of mtDNA data sets
• Communication papers describing new methods, software tools and databases
All Life brings together all researchers with a common goal to improve life. Fostering cross-discipline collaboration and open information sharing to improve reproducibility of research.
The 2030 Agenda for Sustainable Development, adopted by all United Nations (UN) Member States in 2015, produced 17 Sustainable Goals (SDGs) as a “blueprint for peace and prosperity for people and the plant, now and into the future”. Supporting these UN SDGs, All Life broadly provides valuable insights and data towards goals 2 (Zero Hunger), 3 (Good Health and Well-being), 14 (Life Below Water) and 15 (Life on Land) through the following subject areas:
• Aquaculture and Marine Biology (Goal 14)
• Agriculture (Goal 2)
• Bioengineering & Biotechnology (Goal 3 and 15)
• Computational Life sciences, Bioinformatics and System Biology (Goal 3)
• Cancer Biology (Goal 3)
• Biochemistry, Cell and Molecular Biology (Goal 3, 14 and 15)
• Epidemiology, Genetics & Genomic (Goal 3, 14 and 15)
• Microbiology (Goal 3, 14 and 15)
• Molecular Biophysics (Goal 3, 14 and 15)
• Pharmacology & Pharmaceutics (Goal 3)
• Plant Biology (Goal 15)
• Translational Physiology (Goal 3)